Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft mice.
Acta Pharmacol Sin
; 37(6): 825-33, 2016 Jun.
Article
in En
| MEDLINE
| ID: mdl-27133303
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Breast
/
Breast Neoplasms
/
ErbB Receptors
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: